Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men who have been diagnosed with prostate cancer (specifically a type called adenocarcinoma) and are already scheduled to have a standard PSMA-PET scan as part of their routine care, either to check the cancer at the time of first diagnosis or to look for signs that the cancer has come back or progressed
Who may not be able to join:
- People who have a known mental health condition or substance use disorder that, in the treating doctor's opinion, could interfere with taking part in the study
- People who weigh more than 450 pounds (approximately 204 kg), due to the weight limit of the scanning equipment used in the trial
- People with a serious uncontrolled illness — such as an active infection, heart failure with symptoms, unstable chest pain, an irregular heartbeat, or other medical or personal circumstances — that, in the treating doctor's opinion, would make it difficult to follow the study requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Neil Desai, MD, University of Texas Southwestern Medical Center
Phone: 214 648-1836
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Qualitative assessment of RefleXion X1 imaging performance with Illuccix PSMA PET imaging agent immediately following a standard of care Illuccix PET/CT
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.